Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03647163
Title Combination Therapy With Intravenous VSV-IFNbeta-NIS and Pembrolizumab in Refractory NSCLC and HCC
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Vyriad, Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.